Brain cancer patients test CBD for anxiety relief
NCT ID NCT05753007
Summary
This study tested whether a hemp-derived CBD product could help reduce anxiety and improve quality of life in people newly diagnosed with glioblastoma, an aggressive brain cancer. The trial was designed as an 8-week study comparing the CBD product to a placebo in patients receiving standard cancer treatment. The study was terminated early after enrolling only 2 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California San Francisco Brain Tumor Center
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.